Implementing digital PCR : a quality leap for the quantification of nucleic acids
Our analytical development team has implemented an innovative digital PCR (dPCR) equipment for the development and validation of QC methods used on biopharmaceutical products in GMP and non-GMP setups.
Our News :
Press Release
Clean Cells invests over €13M in new biopharmaceutical production site.
5,300 m2 new facility will quadruple analysis and production capacity, becoming largest site in Europe for biopharmaceuticals quality control services and production of cell banks for innovative drugs.
Project will generate up to 80 new job opportunities and fits well within current French and European reindustrialization trend for development of biopharmaceutical products.
Collaboration
Naobios manufactures FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials
Naobios’ development work and GMP manufacturing of vaccine clinical batches will enable FluGen to prepare its 2022 clinical trials in the United States.
Acquisition
Clean Biologics SAS acquires Biodextris Inc.
Transaction enables ArchiMed-backed Clean Biologics group to establish North American presence and expand activities with Biodextris’ complementary services.
Save the date!
Congresses: meet our teams!
Teams at Clean Cells, Naobios and BioDextris are traveling the world to attend major conferences and congresses within the biotech sector.
Discover their agenda in one click.
